Galapagos NV (GLPG) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Galapagos NV shared positive first quarter financial results for 2024, with net revenues rising to €62.4 million, a 7% increase from the previous year, and a significant turnaround to a net profit from continuing operations of €23.5 million. The company has streamlined its operations by transferring its Jyseleca business to Alfasigma and is focusing on expanding its R&D pipeline through strategic collaborations and investments in oncology and immunology. Galapagos is maintaining its cash burn guidance and actively pursuing business development opportunities to strengthen its market position.
For further insights into GLPG stock, check out TipRanks’ Stock Analysis page.